LGMCX
Price
$22.18
Change
+$0.31 (+1.42%)
Updated
Apr 11 closing price
Net Assets
2.63B
RIRBX
Price
$69.17
Change
+$0.98 (+1.44%)
Updated
Apr 11 closing price
Net Assets
103.34B
Ad is loading...

LGMCX vs RIRBX

Header iconLGMCX vs RIRBX Comparison
Open Charts LGMCX vs RIRBXBanner chart's image
Loomis Sayles Global Allocation C
Price$22.18
Change+$0.31 (+1.42%)
VolumeN/A
Net Assets2.63B
American Funds Capital Income Bldr R2
Price$69.17
Change+$0.98 (+1.44%)
VolumeN/A
Net Assets103.34B
LGMCX vs RIRBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LGMCX vs. RIRBX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGMCX is a Buy and RIRBX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RIRBX has more cash in the bank: 103B vs. LGMCX (2.63B). RIRBX pays higher dividends than LGMCX: RIRBX (2.41) vs LGMCX (0.31). LGMCX was incepted earlier than RIRBX: LGMCX (19 years) vs RIRBX (23 years). LGMCX (1.91) is less costly to investors than RIRBX (1.36). RIRBX has a lower initial minimum investment than LGMCX: RIRBX (250) vs LGMCX (2500). RIRBX annual gain was more profitable for investors over the last year : 5.85 vs. LGMCX (-5.82). RIRBX return over 5 years is better than : 37.48 vs. LGMCX (1.03).
LGMCXRIRBXLGMCX / RIRBX
Total Expense Ratio1.911.36140%
Annual Report Gross Expense Ratio1.911.36140%
Fund Existence19 years23 years-
Gain YTD-5.4470.638-854%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.63B103B3%
Annual Yield % from dividends0.312.4113%
Returns for 1 year-5.825.85-99%
Returns for 3 years-7.497.94-94%
Returns for 5 years1.0337.483%
Returns for 10 years12.9227.3147%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBTIX24.57N/A
N/A
Fidelity Advisor Biotechnology I
MRGJX45.83N/A
N/A
MFS Core Equity R4
INSAX18.95N/A
N/A
Catalyst Insider Buying A
EMECX9.59N/A
N/A
Ashmore Emerging Markets Equity C
GMAYX20.32N/A
N/A
GMO Small Cap Quality I